These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19587853

  • 1. Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.
    Engert V, Pruessner JC.
    Curr Neuropharmacol; 2008 Dec; 6(4):322-8. PubMed ID: 19587853
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of action of methylphenidate: insights from PET imaging studies.
    Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ.
    J Atten Disord; 2002 Dec; 6 Suppl 1():S31-43. PubMed ID: 12685517
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.
    Arnsten AF, Dudley AG.
    Behav Brain Funct; 2005 Apr 22; 1(1):2. PubMed ID: 15916700
    [Abstract] [Full Text] [Related]

  • 5. Is contrast sensitivity a physiological marker in attention-deficit hyperactivity disorder?
    Dönmez YE, Özcan ÖÖ, Çankaya C, Berker M, Atas PBU, Güntürkün PN, Ceylan OM.
    Med Hypotheses; 2020 Dec 22; 145():110326. PubMed ID: 33075582
    [Abstract] [Full Text] [Related]

  • 6. Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder.
    Overtoom CC, Verbaten MN, Kemner C, Kenemans JL, van Engeland H, Buitelaar JK, van der Molen MW, van der Gugten J, Westenberg H, Maes RA, Koelega HS.
    Behav Brain Res; 2003 Oct 17; 145(1-2):7-15. PubMed ID: 14529800
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA, Hawi Z, Kirley A, Fitzgerald M, Gill M, Robertson IH.
    Neuropsychopharmacology; 2005 Dec 17; 30(12):2290-7. PubMed ID: 16123773
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS.
    Monden Y, Dan H, Nagashima M, Dan I, Kyutoku Y, Okamoto M, Yamagata T, Momoi MY, Watanabe E.
    Clin Neurophysiol; 2012 Jun 17; 123(6):1147-57. PubMed ID: 22088661
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.
    Takamatsu Y, Hagino Y, Sato A, Takahashi T, Nagasawa SY, Kubo Y, Mizuguchi M, Uhl GR, Sora I, Ikeda K.
    Curr Mol Med; 2015 Jun 17; 15(3):245-52. PubMed ID: 25817856
    [Abstract] [Full Text] [Related]

  • 14. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness.
    Devilbiss DM, Berridge CW.
    Biol Psychiatry; 2008 Oct 01; 64(7):626-35. PubMed ID: 18585681
    [Abstract] [Full Text] [Related]

  • 15. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS, Kantak KM, Dwoskin LP.
    J Neurosci Methods; 2015 Aug 30; 252():55-63. PubMed ID: 25680322
    [Abstract] [Full Text] [Related]

  • 16. Impact of developmental exposure to methylphenidate on rat brain's immune privilege and behavior: Control versus ADHD model.
    Coelho-Santos V, Cardoso FL, Leitão RA, Fontes-Ribeiro CA, Silva AP.
    Brain Behav Immun; 2018 Feb 30; 68():169-182. PubMed ID: 29061363
    [Abstract] [Full Text] [Related]

  • 17. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A, Krauel K, Hinrichs H, Fischer J, Malecki U, Schuetze H, Wolff S, Jansen O, Duezel E, Baving L.
    Brain Res; 2011 May 04; 1388():56-68. PubMed ID: 21385569
    [Abstract] [Full Text] [Related]

  • 18. The Effects of Methylphenidate (Ritalin) on the Neurophysiology of the Monkey Caudal Prefrontal Cortex.
    Tremblay S, Pieper F, Sachs A, Joober R, Martinez-Trujillo J.
    eNeuro; 2019 May 04; 6(1):. PubMed ID: 30847388
    [Abstract] [Full Text] [Related]

  • 19. Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure.
    Farias AC, Cunha A, Benko CR, McCracken JT, Costa MT, Farias LG, Cordeiro ML.
    J Child Adolesc Psychopharmacol; 2010 Apr 04; 20(2):113-8. PubMed ID: 20415606
    [Abstract] [Full Text] [Related]

  • 20. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T, Rohde LA, Hutz MH.
    Am J Pharmacogenomics; 2004 Apr 04; 4(2):83-92. PubMed ID: 15059031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.